The head of the BETonMACE clinical steering committee is Ray K. Kausik.  According to slide #2 of the following presentation Proffessor Ray has participated on the advisory boards of numerous companies including Japanese Pharma giant Takeda:

https://www.resverlogix.com/upload/media_element/249/01/rd-day-october-2016---prof-ray.pdf

According to the following linked article Takeda has earmarked $15 billion USD for pharmaceutical acquistions:

https://www.ft.com/content/5c8e5c50-79c5-11e6-97ae-647294649b28

That article specifically mentions a focus on certain conditions and diseases including Alzheimers.

Okay.....I'm probably stretching things a bit I know.  But this wouldn't be the first instance of wild speculation on here...although its probably the only one that started from a stupid dream about getting on an airplane to go to a scientific conference in Japan.  In that dream I was frantically looking for my passport.....maybe Resverlogix missed the flight.